Have you, or someone you love, recently been diagnosed with advanced colorectal cancer?
 
If so, you or your loved one may be eligible to participate in a new nationwide research study of an investigational drug called panitumumab. The study is called PACCE (Panitumumab Advanced Colorectal Cancer Evaluation) and is being sponsored by Amgen and Absenix.
 
Participants in the study will:

• Gain access to a research treatment that may or may not be as effective as standard therapy
• Help other patients by advancing knowledge of the treatment of colorectal cancer

To learn if you may be eligible to enroll, call Marti, at (509) 838-2531, ext. 4514. Refer to PACCE Trial. Or visit www.amgentrials.com/PACCE.